06.19.26 -- Redefining CAR-T Timing And Patient Access With Allogene Therapeutics' Dr. Zachary Roberts

Choose a development partner who can navigate global execution, ADC-specific challenges, and Project Optimus requirements so your first-in-human study is designed and positioned for success.

Regulatory readiness for global expansion begins in Phase I. A development partner should design your trial and data collection to anticipate downstream regulatory requirements in your target regions.

Can a digital double-check save your trial from data errors? How does verifying shipments at receipt slash inventory mistakes? Discover how to protect protocol integrity and patient safety.

Learn about the deployed methods and actions that were carried out to help a biotech company address clinical operations challenges and meet changing requirements.

Explore the risk factors in small-volume fluid management, learn where manual processes introduce variability, and find out how closed, pump-driven single-use systems can improve accuracy and consistency.